PlainRecalls
FDA Drug Moderate Class II Terminated

WP Thyroid, Westhroid Pure, 1.25 Grain (81.25 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-6050-2 ; b) 30 Tablets, NDC 64727-6050-4; c) 60 Tablets, NDC 64727-6050-5; d) 90 Tablets, NDC 64727-6050-6; e) 100 Tablets, NDC 64727-6050-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

Reported: September 23, 2020 Initiated: August 25, 2020 #D-1610-2020

Product Description

WP Thyroid, Westhroid Pure, 1.25 Grain (81.25 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-6050-2 ; b) 30 Tablets, NDC 64727-6050-4; c) 60 Tablets, NDC 64727-6050-5; d) 90 Tablets, NDC 64727-6050-6; e) 100 Tablets, NDC 64727-6050-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034

Reason for Recall

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Details

Recalling Firm
RLC Labs Inc.
Units Affected
N/A
Distribution
Nationwide in the United States
Location
Phoenix, AZ

Frequently Asked Questions

What product was recalled?
WP Thyroid, Westhroid Pure, 1.25 Grain (81.25 mg) Thyroid USP packaged in a) 1,000 Tablets, NDC 64727-6050-2 ; b) 30 Tablets, NDC 64727-6050-4; c) 60 Tablets, NDC 64727-6050-5; d) 90 Tablets, NDC 64727-6050-6; e) 100 Tablets, NDC 64727-6050-1; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034. Recalled by RLC Labs Inc.. Units affected: N/A.
Why was this product recalled?
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 23, 2020. Severity: Moderate. Recall number: D-1610-2020.